New guidelines for high blood pressure and dyslipidemia: beyond the controversy, are they reliable guides?

Authors

  • Sergio Vásquez-Kunze Facultad de Medicina, Universidad Peruana Cayetano Heredia. Lima, Perú. Departamento de Medicina, Hospital Nacional Cayetano Heredia. Lima, Perú. Médico internista.
  • Germán Málaga Departamento de Medicina, Hospital Nacional Cayetano Heredia. Lima, Perú. CRONICAS Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia. Lima, Perú. Médico internista. magister en Medicina.

DOI:

https://doi.org/10.17843/rpmesp.2014.311.21

Keywords:

Practice guidelines as topic, Hypertension, Dyslipidemias

Abstract

Updates to the Guidelines for the Management of High Blood Pressure and the Guidelines for the Management of Dyslipidemia have been recently published in the eighth report of the Joint National Committee. Both are evidence-based and rely on clinical trial results, leaving aside, when possible, recommendations made by experts. Both have introduced important methodological changes in the form of cataloging and summarizing the evidence used. The High Blood Pressure Guideline is considered to be a reliable guide; it has simplified recommendations and is easy to implement. A potentially interesting change in the Dyslipidemia Guideline is the abandonment of the numerical therapeutic target in order to use the modification of the level of risk, which could promote a discussion about the intensity of treatment, and initiate shared decision-making.

Downloads

Download data is not yet available.

Published

2014-03-14

Issue

Section

Special Section

How to Cite

1.
Vásquez-Kunze S, Málaga G. New guidelines for high blood pressure and dyslipidemia: beyond the controversy, are they reliable guides?. Rev Peru Med Exp Salud Publica [Internet]. 2014 Mar. 14 [cited 2024 Jun. 22];31(1). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/21

Most read articles by the same author(s)

1 2 3 > >>